Allergic contact dermatitis caused by Dermabond(®).
Allergy Department, Metz-Thionville Hospital, 57085, Metz, France. s.lefevre@chr-metz-thionville.fr.|University of Lorraine, Faculty of Medicine, EA 7299, 54500 Vandaeuvre-lès-Nancy, France. s.lefevre@chr-metz-thionville.fr.
Sébastien
http://orcid.org/0000-0002-8806-6623
S
Lefèvre
Department of Dermatology, Military Health Service, Legouest Hospital, 57070, Metz, France.
Aude
A
Valois
Department of Dermatology, Bel-Air Hospital, 57100, Thionville, France.
François
F
Truchetet
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D003487:Cyanoacrylates / Q000009:adverse effects*; D017449:Dermatitis, Allergic Contact / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D006633:Histamine Antagonists / Q000627:therapeutic use; D006801:Humans; D007717:Knee / Q000601:surgery*; D007868:Leg Dermatoses / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D010328:Patch Tests; D011183:Postoperative Complications / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D012882:Skin Tests; D014014:Tissue Adhesives / Q000009:adverse effects*
D000305:Adrenal Cortex Hormones; D003487:Cyanoacrylates; D006633:Histamine Antagonists; D014014:Tissue Adhesives; C100832:octyl 2-cyanoacrylate
2-octyl cyanoacrylate; Dermabond®; allergic reaction; case report; skin adhesive